CIK 0001867096
- Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 871082097
- Phone
- +1 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Exercise or conversion Pieper Steven acquired 19,483 shares (option exercise)
- 4 Open-market buy Director bought 4,515 shares at $2.25 ($10,147)
- 4 Open-market buy Director bought 4,285 shares at $2.37 ($10,134)
- 4 Shares withheld for taxes Hecht Beth gave up 178,006 shares (to pay taxes)
- 4 Shares withheld for taxes JOHNSON KENNETH ERLAND gave up 74,904 shares (to pay taxes)
- 4 Shares withheld for taxes Pieper Steven gave up 204,575 shares (to pay taxes)
- 4 Shares withheld for taxes Shannon John Patrick Jr gave up 271,551 shares (to pay taxes)
- 4 Grant or award McCulloch Kevin acquired 150,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Open-market buy Director bought 5,400 shares at $1.91 ($10,314)
- 4 Other acquisition Director acquired 6,502 shares (other)
- 4 Other acquisition Director acquired 6,474 shares (other)
Page 5 of 9 · 178 filings